As per MRFR analysis, the US Biliary Catheters Market Size was estimated at 657.48 (USD Million) in 2023. The US Biliary Catheters Market Industry is expected to grow from 707.52(USD Million) in 2024 to 1,712.82 (USD Million) by 2035. The US Biliary Catheters Market CAGR (growth rate) is expected to be around 8.369% during the forecast period (2025 - 2035).
The US Biliary Catheters Market is currently experiencing significant trends driven by technological advancements and an increasing prevalence of biliary conditions.
The rise in chronic liver diseases, such as hepatitis and cirrhosis, is creating a growing need for effective biliary interventions.
Moreover, advancements in catheter design and materials are leading to improved patient outcomes, with a focus on enhancing biocompatibility and reducing procedural complications.
This trend is supported by ongoing research and innovation efforts in medical technology, fostering the development of advanced biliary catheter systems that are more effective and easier to use. There are considerable opportunities within the US market as healthcare providers adopt these innovative solutions to better manage biliary drainage and reduce hospital stays.
The shift towards minimally invasive procedures is also creating demand for versatile catheter systems that can be used in various clinical settings. Furthermore, as awareness of biliary diseases increases among the population, healthcare professionals are emphasizing early diagnosis and intervention, which can lead to higher utilization rates of biliary catheters.
Recent times have seen an uptick in partnerships between manufacturing companies and healthcare institutions aimed at streamlining the distribution and accessibility of advanced catheter products. Additionally, regulatory bodies in the US are increasingly approving new products, accelerating their entry into the market while ensuring patient safety and efficacy. This evolving landscape reflects a concerted effort to enhance healthcare delivery systems and the management of biliary diseases, solidifying the importance of innovation and efficacy in the growth of the US Biliary Catheters Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US is witnessing a rising number of cases related to biliary diseases such as cholangitis, bile duct strictures, and biliary obstruction, leading to a heightened demand for biliary catheters. According to the National Institutes of Health, approximately 600,000 people in the US are diagnosed with gallbladder disease annually, contributing to more biliary interventions.
This surge in biliary diseases is driving the US Biliary Catheters Market Industry as healthcare providers increasingly seek advanced catheter solutions to enhance patient outcomes. Additionally, leading organizations like the American Gastroenterological Association are emphasizing innovative treatment methods, which further impacts the growth of the biliary catheters market as technological advancements and patient care standards evolve.
Technological innovation is a pivotal driver in the US Biliary Catheters Market Industry. The introduction of advanced materials and designs, such as biocompatible coatings and minimally invasive techniques, is attracting healthcare institutions' attention. For example, medical device manufacturers like Boston Scientific and Cook Medical are innovating their product lines to include catheters that reduce infection risks and improve insertion techniques.
According to the US Food and Drug Administration reports, there has been a 15% increase in product approvals for innovative bile catheters over the last three years. This evolving technology not only enhances the efficacy of treatments for patients but also supports market expansion.
The demographic shift towards an aging population in the US is significantly boosting the need for biliary catheterization. By the year 2030, the number of individuals aged 65 and older is projected to exceed 73 million according to the Administration on Aging.
As older adults are more susceptible to biliary tract diseasesmany of which require catheter implantation for treatment optionsthe US Biliary Catheters Market Industry is expected to thrive. Organizations such as AARP advocate for improved healthcare services that address the needs of the elderly, which has prompted medical facilities to increase their investment in biliary products, fostering market growth.
The US government and private sectors are ramping up investments in healthcare infrastructure, significantly affecting the availability of advanced biliary catheters. In 2021, the US government announced a substantial increase in funding aimed at modernizing healthcare facilities across the country to improve patient care.
This emphasis on upgrading medical infrastructures, as highlighted by the Centers for Medicare and Medicaid Services initiatives, ensures that hospitals are now better equipped to implement the latest technologies. This influx of funding is positively influencing the US Biliary Catheters Market Industry, allowing healthcare providers to acquire cutting-edge medical devices, including biliary catheters, which increases their adoption in clinical settings.
The US Biliary Catheters Market has been experiencing notable growth, with the Type segment playing a crucial role in this expansion.
Within this segment, the various types of biliary catheters, including Drainage, Sump Catheter, Biliary Drainage Catheter, and Nephrostomy, cater to distinct clinical needs, enhancing their strategic significance in healthcare settings across the United States.
Drainage catheters are critical in managing biliary obstructions, allowing for effective drainage and relief from symptoms associated with such conditions.
Sump Catheters are essential in situations requiring continuous drainage and are designed to provide a dual lumen system, which aids in maintaining optimal flow while preventing clogging. Biliary Drainage Catheters hold a pivotal position as they facilitate both diagnostic and therapeutic procedures, allowing for interventional radiology to address various hepatic and biliary diseases. Lastly, Nephrostomy catheters also find a place within this market segment, offering crucial renal drainage options for patients with urinary tract obstructions. All these factors contribute to the overall demand and market dynamics, which are driven by the prevalence of biliary tract diseases and the growing adoption of minimally invasive procedures across the US. As healthcare providers increasingly focus on patient-centered care, the demand for effective biliary intervention tools is expected to grow, reflecting the ongoing trends and needs within the US Biliary Catheters Market industry.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Application segment of the US Biliary Catheters Market continues to evolve, driven by a rising prevalence of biliary disorders and a growing population seeking medical interventions.
Within this market, various applications such as Thrombectomy, Occlusion, and Infusion play crucial roles in managing complex conditions.
Thrombectomy is essential for patients experiencing blood clots, while Occlusion Devices applications are vital for addressing occlusive diseases through catheter interventions, showcasing the importance of these methods for procedural efficiency.
Infusion applications also hold significant ground as they allow for targeted drug deliveries, improving treatment efficacy. Furthermore, Dialysis and Diagnostic capabilities ensure comprehensive care in renal and diagnostic settings, reflecting the multi-faceted use of biliary catheters. Monitoring applications enhance patient management, underscoring the market's shift towards preventative healthcare. This segmentation highlights the diverse utility of biliary catheters in treating life-threatening conditions and enhances clinical outcomes across procedures. The ongoing advancements and innovations in these application areas are expected to significantly influence the overall growth of the US Biliary Catheters Market.
The US Biliary Catheters Market is significantly structured around its End User segment, primarily comprising Clinics and Hospitals.
Clinics play a pivotal role in providing outpatient care and specialized procedures for patients with biliary conditions, which contributes to the increased utilization of biliary catheters in diagnostic and therapeutic measures.
Hospitals, on the other hand, are critical players in this market, equipped with advanced technology and facilities for complex treatments, thereby dominating a larger portion of the market.
The rising prevalence of liver diseases and gallbladder disorders in the US emphasizes the necessity of these healthcare settings to effectively manage patient care. With advancements in medical technology and a growing focus on minimally invasive procedures, the demand for biliary catheters is expected to rise, propelling the market forward. Additionally, hospitals often invest in Research and Development initiatives to enhance treatment protocols, thus encouraging the growth of the US Biliary Catheters Market. Enhanced awareness and education regarding biliary diseases among healthcare professionals and patients alike are also driving factors contributing to the expansion of this market segment.
The competitive landscape of the US Biliary Catheters Market is characterized by a range of established and emerging players vying for market share through innovation, product development, and strategic partnerships. As healthcare continues to evolve, these companies are increasingly focusing on technological advancements to enhance the efficacy and safety of biliary procedures. The market is driven by the increasing incidence of biliary diseases, the aging population, and the growing demand for minimally invasive surgical procedures. The competitive dynamics also reflect shifts in regulatory landscapes, healthcare policies, and changing consumer preferences that influence the market's growth trajectory. Companies are leveraging cutting-edge technologies and expanding their product portfolios to cater to diverse medical needs, thus intensifying competition within the sector.
C.R. Bard holds a significant position in the US Biliary Catheters Market, known for its innovative medical devices that meet specific clinical needs. The company has established a robust distribution network that enables it to penetrate various healthcare facilities across the United States effectively. C.R. Bard's strengths lie in its commitment to quality and safety, supported by rigorous research and development processes that lead to the creation of reliable and effective biliary catheter products. The company also benefits from its strong reputation in the healthcare sector, driven by its history of excellence and clinical evidence supporting its products. Additionally, C.R. Bard’s strategic collaborations with healthcare providers and its emphasis on customer engagement further bolster its market presence.
Gyrus ACMI has positioned itself strategically in the US Biliary Catheters Market, leveraging its extensive experience in surgical tools and devices. The company is recognized for its innovative technologies that complement minimally invasive surgeries, enhancing the procedural efficacy of biliary interventions. Gyrus ACMI's portfolio includes premier products designed to facilitate better patient outcomes, including advanced biliary catheters. The company focuses on continual improvement and investment in research and development, enabling it to keep pace with changing market demands. Notably, Gyrus ACMI has undergone several mergers and acquisitions aimed at expanding its market footprint and enhancing its product offerings, further solidifying its competitive stance in the US. The integration of new technologies and focus on customer-centric solutions contribute to Gyrus ACMI's strengths within this specialized market.
Key Companies in the US Biliary Catheters Market Include
The US Biliary Catheters Market has seen notable developments recently, particularly with advances in device technology and increasing demand due to rising cases of biliary diseases. Companies such as Boston Scientific and Medtronic are focusing on innovations to enhance patient outcomes, with Medtronic launching a new line of biliary catheters designed for improved navigation and delivery.
Current affairs indicate a growing trend in outpatient procedures, leading to increased market valuation driven by efficiency and cost-effectiveness in healthcare settings. In terms of mergers and acquisitions, C.R. Bard's acquisition by Becton Dickinson in December 2017 continues to shape competitive dynamics in the market, consolidating product offerings and expanding market reach for both organizations.
Additionally, the ongoing collaboration discussions between Abbott Laboratories and Johnson and Johnson center around R&D initiatives aimed at developing next-generation biliary solutions. The market is projected to experience significant growth as hospitals increasingly adopt advanced biliary interventions, influenced by technological advancements and supportive regulatory frameworks in the US healthcare landscape, bolstering overall market performance over the last few years.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 657.48(USD Million) |
| MARKET SIZE 2024 | 707.52(USD Million) |
| MARKET SIZE 2035 | 1712.82(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.369% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | C.R. Bard, Gyrus ACMI, Terumo Corporation, MicroTech, Angiodynamics, Boston Scientific, Abbott Laboratories, Medtronic, Stryker Corporation, Cook Medical, Asahi Intecc, Halyard Health, Endo International, Johnson and Johnson, Becton Dickinson |
| SEGMENTS COVERED | Type, Application, End User |
| KEY MARKET OPPORTUNITIES | Increasing geriatric population, Rising prevalence of liver diseases, Advancements in catheter technology, Growing demand for minimally invasive procedures, Expansion of healthcare infrastructure |
| KEY MARKET DYNAMICS | Increasing prevalence of liver diseases, Growing demand for minimally invasive procedures, Advances in catheter technology, Rising elderly population, Expansion of healthcare facilities |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Biliary Catheters Market is expected to be valued at 707.52 million USD in 2024.
By 2035, the US Biliary Catheters Market is expected to reach a value of 1712.82 million USD.
The expected CAGR for the US Biliary Catheters Market from 2025 to 2035 is 8.369%.
The Biliary Drainage Catheter segment is expected to have the largest market size, valued at 250 million USD in 2024.
The Drainage segment is valued at 150 million USD in 2024 and is projected to reach 370 million USD by 2035.
Key players in the US Biliary Catheters Market include C.R. Bard, Boston Scientific, Abbott Laboratories, and Medtronic among others.
The Sump Catheter segment is anticipated to reach a market size of 290 million USD by 2035.
The Nephrostomy segment is valued at 187.52 million USD in 2024.
Emerging trends and advancing technology provide substantial growth opportunities within the US Biliary Catheters Market.
By 2035, each segment such as Biliary Drainage Catheter and Nephrostomy is projected to grow significantly, driving overall market expansion.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
